MiCo BioMed Co., Ltd. (KOSDAQ: 214610)
South Korea
· Delayed Price · Currency is KRW 1,400.00
-25.00 (-1.75%)
Jan 17, 2025, 9:00 AM KST
MiCo BioMed Revenue
MiCo BioMed had revenue of 2.48B KRW in the quarter ending September 30, 2024, with 76.25% growth. This brings the company's revenue in the last twelve months to 8.30B, up 61.39% year-over-year. In the year 2023, MiCo BioMed had annual revenue of 5.37B, down -66.69%.
Revenue (ttm)
8.30B
Revenue Growth
+61.39%
P/S Ratio
6.45
Revenue / Employee
116.94M
Employees
71
Market Cap
57.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.37B | -10.74B | -66.69% |
| Dec 31, 2022 | 16.11B | -14.19B | -46.83% |
| Dec 31, 2021 | 30.30B | -15.37B | -33.65% |
| Dec 31, 2020 | 45.67B | 41.57B | 1,014.47% |
| Dec 31, 2019 | 4.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |